ArticleBiomedical reports2025
Relationships between intervertebral disc degeneration and lysyl oxidase expression in human nucleus pulposus.
Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Musculoskeletal disorders: does cuproptosis hold the key?Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The collagen and elastin are important components of extracellular matrix (ECM) in the nucleus pulposus (NP), which can produce water-insoluble proteins through cross-linkages to stabilize ECM. Lysyl oxidase (LOX), a copper-dependent amine oxidase, insolubilizes ECM proteins to keep the stability of ECM by initiating collagen and elastin cross-linkages. The present study aimed to investigate the relationships between intervertebral disc (IVD) degeneration and LOX expression in human NP. A total of 22 cases with lumbar IVD degeneration were designed to the observed group and the control group consisted of 4 young patients with the need of surgically removing the IVD due to lumbar vertebra fracture caused by sudden trauma. These patients were grouped based on Pfirrmann grades of IVDs. The control group represented grade I (group A) and the observed group was subdivided into 4 group: Grade II (group B), grade III (group C), grade IV (group D) and grade V (group E). The herniated NP of each group was prepared for immunohistochemistry, western blotting and reverse transcription-quantitative PCR. The present results showed that the number of NP cells and the components of ECM were significantly lower in the observed group than in the control group. There was an inverse association of the expression rate of LOX NP cells with Pfirrmann grades and age. The protein expression of LOX in group A, B, C, D and E was 2.69±0.24, 2.24±0.32, 1.34±0.19, 1.3±0.32 and 1.01±0.12, respectively. The mRNA expression of LOX in Group A, B, C, D and E was 1±0.03, 0.83±0.07, 0.71±0.09, 0.53±0.09 and 0.27±0.05, respectively. With increasing IVD degeneration, the protein and mRNA expression levels of LOX in NP decreased gradually. Taken together, the findings of the present study revealed that the protein and mRNA expression levels of LOX were decreased with increasing IVD degeneration. These findings provide new insights that LOX might involve in the occurrence and development of IVD degeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.